Network-Based Analysis for the discovery of diagnostic biomarkers

Event Details

  • Date:
  • Categories:

Modern biological network based techniques webinar and demonstration as a tool for the discovery of diagnostic biomarkers.

Biological networks have always been a strong tool for bioinformaticians to study the complex underlying mechanisms of diseases. However, their application for the discovery of predictive biomarkers is limited. Biomarker discovery on the other hand is the common denominator of pharma and healthcare R&D and a very difficult problem to solve computationally considering the large number of potential biomarkers and relatively small number of samples in most studies.

In this webinar, the attendees were introduced to modern biological networks techniques, using academic and commercial tools and how these can be used to facilitate biomarkers discovery, to catalyze training accurate diagnostic tools and to promote our understanding on complex diseases.

The webinar was delivered by Dr. Konstantinos Theofilatos, Chief Technology Officer at InSyBio.

Konstantinos Theofilatos is a computer engineer with MSc and PhD in Bioinformatics from University of Patras (Greece). He is a highly experienced bioinformatician and programmer. The last 15 years, he has worked as a researcher, software engineer and bioinformatician in several Developmental and Research projects. Also, he has worked as a teaching collaborator in the Technological Institutes of Messologhi, Argostoli and Naupaktos, Greece, while at the moment he is a Lecturer in Bioinformatics in King’s College London. His main R&D activity is related with bioinformatics applications and his research interests include computational intelligence, bioinformatics, data mining, web technologies and time series forecasting. So far, he has published more than 45 articles in international scientific journals and more than 50 articles in conference proceedings, 2 edited volumes-books, 4 book chapters while he is the co-inventor in two submitted patents in US Patent office and has an h-index of 15. He is the co-founder and CTO of InSyBio Ltd, a biotechnology and bioinformatics company which delivers a cloud-based software suite for intelligent analysis of biological data and biomarkers discovery.



In the video of this webinar you will find out how modern biological networks techniques can be used to facilitate biomarkers discovery for training diagnostic tools and to promote our understanding on complex diseases. Get the link here:


About InSyBio: InSyBio is an international pioneer bioinformatics revolutionizing the medical field, clinical trials and food/nutrition industries through targeted biomarker discovery and highly-accurate predictive analytics.

Its solutions provide the R&D departments of Pharma, Research Institutes and Food/Nutrition companies, with the means both analytically and computationally to meet their challenging research and innovation goals (such as robust biomarker discovery and accurate predictive models). This is done through a sophisticated, software-as-a-service, machine learning platform which comprehensively integrates multi-omics data reducing the number of samples and additional validation experiments needed. Since 2013, InSyBio has worked with hundreds of academics, large and small companies, hospitals and research centers allowing them to succeed in their biomarker discovery tasks with an increase of at least 10% in predictive accuracy and decrease of at least 80% in overall time and cost.

Visit to see how InSyBio can help you reach your R&D goals in the era of Precision Medicine and Nutrition.

Scroll to top